Page 15 - Umer Raffat News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Umer Raffat. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Umer Raffat Today - Breaking & Trending Today

Teva Pharmaceutical Industries (TEVA) Q2 2023 Earnings Call Transcript

Published: August 2, 2023

TEVA earnings call for the period ending June 30, 2023.

Source: fool.com

Related Topics:

United StatesBalaji PrasadSven DethlefsThibault BoutherinDavid Amsellem Piper SandlerRichard FrancisChris Schott JpmorganJason GerberryMikaela Franceschina BarclaysAmerica Merrill LynchPiper SandlerEric HughesThibault Boutherin Morgan StanleyZyprexa RelprevvDavid AmsellemChris SchottTeva Pharmaceutical IndustriesAmerican Academy Of NeurologyMorgan StanleyCompany AnalystJason Gerberry BankHead Of ResearchPharmaceutical Industries LimitedEran MeirVice President

Apellis faces safety doubts for fast-selling eye drug

Published: July 31, 2023

BioPharma

Source: biopharmadive.com

Related Topics:

United StatesCedric FrancoisJon MillerCaroline BaumalAnnabel SamimyIveric BioApellis PharmaceuticalsDrug AdministrationAmerican Society Of Retinal SpecialistsAmerican SocietyRetinal SpecialistsStat NewsWall StreetUmer RaffatChief Medical Officer Caroline

Biogen Inc. (NASDAQ:BIIB) Q2 2023 Earnings Call Transcript

Published: July 28, 2023

Operator: Good morning. My name is Ruth and I'll be your conference operator today.

Source: insidermonkey.com

Related Topics:

South KoreaUnited KingdomUnited StatesGreat BritainMike McdonnellChris ViehbacherBrian SkorneyChuck TrianoChris SchottRobin KramerTim AndersonMarc GoodmanMichael McdonnellRobyn KarnauskasChristopher ViehbacherPriya SinghalSamsung BioepisSalveen RichterPaul MatteisMichael YeeSusan LangerBrian AbrahamsEvan SeigermanMohit BansalWolfe Research

Biogen (BIIB) Q2 2023 Earnings Call Transcript

Published: July 25, 2023

BIIB earnings call for the period ending June 30, 2023.

Source: fool.com

Related Topics:

South KoreaUnited KingdomUnited StatesGreat BritainRobyn KarnauskasChris ViehbacherSalveen Richter Goldman SachsRobyn Karnauskas TruistSusan LangerChristopher ViehbacherPriya SinghalBrian SkorneySalveen RichterChris Schott JpmorganLynn KramerEvan SeigermanSamsung BioepisPaul MatteisFadia NeedhamMike Yee JefferiesMichael YeeChris SchottMike McdonnellTim AndersonMarc Goodman

Apellis shares sink on reports of rare side effects with new vision loss drug

Published: July 17, 2023

BioPharma

Source: biopharmadive.com

Related Topics:

United StatesIveric BioDemetrios VavvasJon MillerDrug AdministrationAmerican Society Of Retinal SpecialistsHarvard Medical SchoolRetina Service At Massachusetts EyeApellis PharmaceuticalAmerican SocietyRetinal SpecialistsBiopharma DiveUmer RaffatWall StreetRetina ServiceMassachusetts Eye